Latest & greatest articles for overdiagnosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on overdiagnosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on overdiagnosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for overdiagnosis

1. Overdiagnosis

Overdiagnosis Top results for overdiagnosis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for overdiagnosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

2. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 Cancer Australia

3. THESIS: Preventing Overdiagnosis, the Quaternary Prevention

THESIS: Preventing Overdiagnosis, the Quaternary Prevention THESIS: Preventing Overdiagnosis, the Quaternary Prevention — Less is More Medicine Discover Act About Nanaimo BC Phone Number Putting the focus on effective, appropriate, and good-value healthcare Your Custom Text Here March 20, 2018 Maria Llargués Pou, a soon-to-be Family Physician in Barcelona, recently shared with me her Bachelor's Thesis. Her work - "Primum non nocere " Preventing Overdiagnosis, the Quaternary Prevention provides (...) , contemporary efforts to tackle overdiagnosis, like the Choosing Wisely Campaign and Preventing Overdiagnosis conference. Her paper serves as a great "backgrounder" for those who wish to learn more about the broad themes and history of this movement. You can view the full text In , , Tags , , , , , , , articles and Original Commentary on the topic of "Less is More in Medicine" and The "Right Care" SITE SEARCH: SUBSCRIBE: E-mail updates: SIMILAR BLOGS: (ES) (not affiliated) (BP) CATEGORIES: TWEETS: RT

2018 Less is More in Medicine Blog

4. Overdiagnosis: what it is and what it isn?t Full Text available with Trip Pro

Overdiagnosis: what it is and what it isn?t Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis: what it is and what it isn’t Article Text Editorial Overdiagnosis: what it is and what it isn’t Free John Brodersen , , Lisa M Schwartz , Carl Heneghan , Jack William O’Sullivan , Jeffrey K Aronson , Steven Woloshin Statistics from Altmetric.com Why then, can one desire too much

2018 Evidence-Based Medicine

5. A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month

A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month By on October 13, 2016. I knew it. I just knew it. I knew I couldn’t get through October, a.k.a. Breast Cancer Awareness Month, without a controversial (...) mammography study to sink my teeth into. And I didn’t. I suppose I should just be used to this now. I’m referring to the latest opus from H. Gilbert Welch and colleagues that appeared in the New England Journal of Medicine last night, . Yes, it’s about overdiagnosis, something I’ve blogged about more times than I can remember now, but it’s actually a rather interesting take on the issue. Before 2008 or so, I never gave that much thought to the utility of mammographic screening as a means of early

2016 Respectful Insolence

6. Overdiagnosis in primary care: framing the problem and finding solutions. Full Text available with Trip Pro

Overdiagnosis in primary care: framing the problem and finding solutions. Overdiagnosis, is defined as the diagnosis of a condition that, if unrecognized, would not cause symptoms or harm a patient during his or her lifetime, and it is increasingly acknowledged as a consequence of screening for cancer and other conditions. Because preventive care is a crucial component of primary care, which is delivered to the broad population, overdiagnosis in primary care is an important problem from (...) a public health perspective and has far reaching implications. The scope of overdiagnosis as a result of services delivered in primary care is unclear, though overdiagnosis of indolent breast, prostate, thyroid, and lung cancers is well described and overdiagnosis of chronic kidney disease, depression, and attention-deficit/hyperactivity disorder is also recognized. However, overdiagnosis is a known consequence of all screening and can be assumed to occur in many more clinical contexts. Overdiagnosis

2018 BMJ

7. How overdiagnosis produced a nonexistent “epidemic” of thyroid cancer in Fukushima

How overdiagnosis produced a nonexistent “epidemic” of thyroid cancer in Fukushima How overdiagnosis produced a nonexistent "epidemic" of thyroid cancer in Fukushima | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation How overdiagnosis produced a nonexistent "epidemic" of thyroid cancer in Fukushima By on March 20, 2016. One of my favorite topics to blog about over the last six or seven years has been the topic of and . These are two interrelated phenomena that most (...) people are blissfully unaware of. Unfortunately, I'd also say that the majority of physicians are only marginally more aware than the public about these confounders of screening programs, if even that. Overdiagnosis has long been appreciated to be a major impediment to translating programs to screen for disease into better outcomes in a number of diseases but has only recently really seeped into the public consciousness, beginning in particular in 2009 when the United States Preventative Services

2016 Respectful Insolence

8. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. Full Text available with Trip Pro

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. To quantify the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.Modelling and validation of the lifetime risk method using publicly available population data.Opportunistic screening for prostate cancer in the Australian population.Australian (...) male population (1982-2012).Prostate-specific antigen testing for prostate cancer screening.Primary: lifetime risk of overdiagnosis in 2012 (excess lifetime cancer risk adjusted for changing competing mortality); Secondary: lifetime risk of prostate cancer diagnosis (unadjusted and adjusted for competing mortality); Excess lifetime risk of prostate cancer diagnosis (for all years subsequent to 1982).The lifetime risk of being diagnosed with prostate cancer increased from 6.1% in 1982 (1 in 17

2019 BMJ open

9. The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma Full Text available with Trip Pro

The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma The 2015 guidelines from the American Thyroid Association for adults with thyroid nodules and differentiated thyroid may be particularly important in minimising potential harm from overdiagnosis and overtreatment of thyroid tumours by providing more restrictive indications for biopsy of thyroid

2018 European Endocrinology

10. Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis

Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Article Text Therapeutics/Prevention Observational study US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Rebecca A Hubbard Statistics from Altmetric.com Commentary on: Harding C , Pompei F , Burmistrov D , et al . Breast Cancer Screening, Incidence

2015 Evidence-Based Medicine

11. Overdiagnosis from mammographic screening

Overdiagnosis from mammographic screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 MHRA Drug Safety Update

12. Medicine: more precise, more effective, but more overdiagnosis

Medicine: more precise, more effective, but more overdiagnosis Medicine: more precise, more effective, more overdiagnosis | BMJ EBM Spotlight by I’m at the 6th preventing overdiagnosis conference chairing a session on Overdiagnosis 2.0 (Technology) by , & . So I thought I’d share some insights. Carl Heneghan at Preventing Overdiagnosis from the GP research unit at Trondheim talked about the impact of new technology ‘that is heavily geared to screening, which will create a new era (...) of overdiagnosis.’ Up to now, Henrik argued, that screening has been about using a few biomarkers in select populations. However, in this new era of wearables and smart technology, there will be multiple opportunities to screen largely well individuals, more or less all the time. ‘Big data precision medicines entails a massive, new form of screening (screening 2.0),’ he said. Here’s an example form this week’s New York Times: ‘researchers are now building a website that will allow anyone to upload genetic data

2018 Evidence-Based Medicine blog

13. Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Full Text available with Trip Pro

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Screening for prostate cancer is frequent in high-income countries, including Switzerland. Notably due to overdiagnosis and overtreatment, various organisations have recently recommended against routine screening, potentially having an impact on incidence, mortality, and surgery rates. Our aim was therefore to examine whether secular trends in the incidence and mortality (...) and prostatectomy observed in Switzerland among men younger than 70 years have concomitantly leveled off around 2002/2003. Given the decreasing mortality, these trends may reflect recent changes in screening and clinical workup practices, with a possible attenuation of overdiagnosis and overtreatment.

2019 PLoS ONE

14. COPD Overdiagnosis, Underdiagnosis, and Treatment Full Text available with Trip Pro

COPD Overdiagnosis, Underdiagnosis, and Treatment This article serves as a CME-available enduring material summary of the following COPD9USA presentations: - "Spirometry Isn't for Screening - So What Is?" Presenter: David H. Au, MD, MS - "Diagnosis of COPD in a Primary Care Midwest Practice" Presenter: Barbara Yawn, MD, MSc - "What Happens in Primary Care Without Screening?" Presenter: Sandra G. Adams, MD, MS - "From Screening to Diagnosis to Management in a Busy Primary Care Practice"Presenter

2016 Chronic Obstructive Pulmonary Diseases

15. Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. (Abstract)

Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. Shared patient-physician decision-making regarding treatment for prostate cancer detected by prostate-specific antigen screening involves a complex calculus weighing the risk of the cancer and patient life expectancy. We investigated quantifying these competing risks using the probability that the cancer was "overdiagnosed"-i.e., would not have been (...) clinically diagnosed (diagnosed without screening) during the patient's remaining lifetime.Using an established model of prostate cancer screening and clinical diagnosis, we simulated screen-detected cases and determined whether modeled clinical diagnosis would occur before non-cancer death, which was based on comorbidity-adjusted population lifetables. Logistic regression models were fitted to the simulated data and used to estimate overdiagnosis probabilities given patient age, PSA level, Gleason sum

2019 Journal of Urology

16. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. Full Text available with Trip Pro

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. To investigate patterns of industry-sponsored educational events that focus on specific health conditions for which there are concerns about overdiagnosis and overtreatment.This retrospective cohort study examines publicly reported industry-sponsored events in Australia from October 2011 to September 2015 for three conditions (...) potentially subject to overdiagnosis and overtreatment: depression, osteoporosis and overactive bladder. We used a database of transparency reports to identify events with a focus on depression, osteoporosis and overactive bladder and compared these with other sponsored events. We hypothesised that companies marketing treatments for each condition would sponsor related events and that target audiences would mainly work in primary care, reflecting a broad patient population.Event and attendee

2018 BMJ open

17. Helen Macdonald: Overdiagnosis and the fear of being “normal”

Helen Macdonald: Overdiagnosis and the fear of being “normal” Helen Macdonald: Overdiagnosis and the fear of being "normal" - The BMJ ---> Helen Macdonald discusses the key points from Day 1 of Preventing Overdiagnosis “Why we are so afraid to be normal?” asked, as she opened the 2018 Preventing Overdiagnosis conference in Copenhagen. It was a typically thought provoking opening from the retired GP, who is a core member of the scientific committee for the conference. It can be easy to lose (...) sight of patients when you are sitting in a lecture theatre. But Iona managed to make them feel close. Why are doctors so keen to rush to diagnosis, convinced of their own rightness? Doctors almost don’t seem to like people being “normal.” And preventive medicine seems the order of the day. Perhaps because human life is a precarious condition. , a GP from Norway, talked about diagnosis and overdiagnosis throughout his career. “In the beginning was the word,” he said. But nowadays it can be difficult

2018 The BMJ Blog

18. Wake up and smell the #overdiagnosis

Wake up and smell the #overdiagnosis Wake up and smell the #overdiagnosis — Less is More Medicine Discover Act About Nanaimo BC Phone Number Putting the focus on effective, appropriate, and good-value healthcare Your Custom Text Here December 1, 2016 Alan Cassels is not a shy kind of guy. He tells it like it is and is not one to stay quiet even if what he says may be unpopular. And usually it is pretty unpopular. However, it is necessary. From calling out the to and digging into the , he (...) is not afraid to talk about the elephants in the room, when it seems no one else is willing. Cassels is a policy analyst, , and champion debunker when it comes to pharmaceutical policy and the medicalization of Canadians. In his most recent article for Focus Magazine, Cassels highlighted the Preventing Overdiagnosis conference, the harms of prostate cancer screening, and my perspective on the issues. I've had the chance to work with Cassels on a few small projects but to be called a 'resistor' by him feels

2016 Less is More in Medicine Blog

19. A systematic review of the interventions aiming at reducing overdiagnosis and the overuse of diagnostic imaging in the emergency department and inpatient settings when a pulmonary embolism is suspected

A systematic review of the interventions aiming at reducing overdiagnosis and the overuse of diagnostic imaging in the emergency department and inpatient settings when a pulmonary embolism is suspected Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files

2016 PROSPERO

20. Preventing Overdiagnosis

Preventing Overdiagnosis Preventing Overdiagnosis 2019 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Preventing Overdiagnosis 2019 Conference, 5 - 7 December 2019, Sydney, Australia Details 8:00 am, December 5, 2019 — 5:00 pm, December 7, 2019 Venue University of Sydney The Preventing Overdiagnosis conference covers how physicians, researchers and patients can implement solutions to the problems (...) of overdiagnosis and overuse in the healthcare system using evidence available and that currently being generated. We offer a platform for delegates to learn how to avoid waste, use best practice when communicating and engaging with patients and the public, and achieve a better understanding of the benefits of shared decision making within the constraints of modern practice. POD conferences continue working towards making our health systems safe sustainable and successful well into the future. 02 July 2019

2017 CEBM blog